Time to Disease Recurrence Is a Predictor of Metastasis and Mortality in Patients with High-risk Prostate Cancer Who Achieved Undetectable Prostate-specific Antigen Following Robot-assisted Radical Prostatectomy.
Do Kyung KimKyo Chul KooKwang-Suk LeeYoon Soo HahKoon Ho RhaSung Joon HongByung Ha ChungPublished in: Journal of Korean medical science (2018)
RARP confers acceptable oncological outcomes for high-risk PCa. Close monitoring beyond 5 years is warranted for early detection of disease progression and for timely adjuvant therapy.